ArticleBritish journal of haematology2025

Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin-bleomycin-vinblastine-dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study.

C Giordano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.